AAP
OLMA icon

Arax Advisory Partners’s Olema Pharmaceuticals OLMA Stock Holding History

Arax Advisory Partners’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
+1,445
New +$19.4K ﹤0.01% 4023
2026
Q1 		– Sell
-564
Closed -$14.1K – 4177
2025
Q4 		$14.1K Buy
564
+559
+11,180% +$9.95K ﹤0.01% 2307
2025
Q3 		$49 Buy
+5
New +$30 ﹤0.01% 3533
2025
Q1 		– Sell
-65
Closed -$379 – 2933
2024
Q4 		$379 Buy
+65
New +$649 ﹤0.01% 2347

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Arax Advisory Partners's OLMA Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 1,445 shares worth $18.1K. The stake represents ﹤0.01% of the portfolio and ranks #4023 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in OLMA as recently as Q4 2025.

Arax Advisory Partners first reported a position in OLMA in Q4 2024 and has held it in 4 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Arax Advisory Partners held 1,445 shares of Olema Pharmaceuticals worth $18.1K as of Q2 2026.
  • Olema Pharmaceuticals was a new Arax Advisory Partners position in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4023 holding.
  • Arax Advisory Partners first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.